EP4022094A4 - Biomarker zur diagnose von lungenkrebs - Google Patents
Biomarker zur diagnose von lungenkrebs Download PDFInfo
- Publication number
- EP4022094A4 EP4022094A4 EP20857896.3A EP20857896A EP4022094A4 EP 4022094 A4 EP4022094 A4 EP 4022094A4 EP 20857896 A EP20857896 A EP 20857896A EP 4022094 A4 EP4022094 A4 EP 4022094A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- biomarkers
- diagnosis
- lung cancers
- cancers
- lung
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000090 biomarker Substances 0.000 title 1
- 238000003745 diagnosis Methods 0.000 title 1
- 208000020816 lung neoplasm Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57423—Specifically defined cancers of lung
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Physics & Mathematics (AREA)
- Hospice & Palliative Care (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP23174278.4A EP4257982A3 (de) | 2019-08-26 | 2020-08-26 | Biomarker zur diagnose von lungenkrebs |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962891943P | 2019-08-26 | 2019-08-26 | |
| US201962893088P | 2019-08-28 | 2019-08-28 | |
| US201962902943P | 2019-09-19 | 2019-09-19 | |
| PCT/US2020/048019 WO2021041556A1 (en) | 2019-08-26 | 2020-08-26 | Biomarkers for the diagnosis of lung cancers |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP23174278.4A Division EP4257982A3 (de) | 2019-08-26 | 2020-08-26 | Biomarker zur diagnose von lungenkrebs |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP4022094A1 EP4022094A1 (de) | 2022-07-06 |
| EP4022094A4 true EP4022094A4 (de) | 2022-11-30 |
Family
ID=74684360
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP20857896.3A Withdrawn EP4022094A4 (de) | 2019-08-26 | 2020-08-26 | Biomarker zur diagnose von lungenkrebs |
| EP23174278.4A Pending EP4257982A3 (de) | 2019-08-26 | 2020-08-26 | Biomarker zur diagnose von lungenkrebs |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP23174278.4A Pending EP4257982A3 (de) | 2019-08-26 | 2020-08-26 | Biomarker zur diagnose von lungenkrebs |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US11198912B2 (de) |
| EP (2) | EP4022094A4 (de) |
| JP (1) | JP2023504334A (de) |
| WO (1) | WO2021041556A1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113252806B (zh) * | 2021-03-25 | 2023-08-29 | 嘉兴学院 | S-腺苷同型半胱氨酸在制备用于诊断或治疗川崎病的产品中的用途 |
| WO2023152568A2 (en) * | 2022-02-10 | 2023-08-17 | Oslo Universitetssykehus Hf | Compositions and methods for characterizing lung cancer |
| CN114705863B (zh) * | 2022-04-27 | 2023-06-06 | 郑州大学第一附属医院 | Ssh3蛋白在贲门腺癌预后预测中的应用 |
| CN115040637A (zh) * | 2022-05-24 | 2022-09-13 | 中南大学湘雅医院 | Rcn2重组蛋白在制备预防和/或治疗骨质疏松症以及提升免疫力的药物中的应用 |
| CN114874308B (zh) * | 2022-05-26 | 2023-02-17 | 苏州大学 | 一种核素标记的抑制肽及其制备方法和应用 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2305811A1 (de) * | 2005-07-27 | 2011-04-06 | Oncotherapy Science, Inc. | Verfahren zur Diagnose von kleinzelligem Lungenkrebs |
| US20110236903A1 (en) * | 2008-12-04 | 2011-09-29 | Mcclelland Michael | Materials and methods for determining diagnosis and prognosis of prostate cancer |
| WO2018213764A1 (en) * | 2017-05-19 | 2018-11-22 | Lunella Biotech, Inc. | Companion diagnostics for mitochondrial inhibitors |
| WO2019008414A1 (en) * | 2017-07-05 | 2019-01-10 | Datar Rajan | GENE EXPRESSION ANALYSIS BASED ON EXOSOMES FOR THE CARE OF CANCER |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070065844A1 (en) * | 2005-06-08 | 2007-03-22 | Massachusetts Institute Of Technology | Solution-based methods for RNA expression profiling |
| US20120004116A1 (en) * | 2008-12-04 | 2012-01-05 | Ming-Sound Tsao | Methods for biomarker identification and biomarker for non-small cell lung cancer |
| EP2336353A1 (de) * | 2009-12-17 | 2011-06-22 | febit holding GmbH | miRNA-Fingerabdrücke bei der Diagnose von Krankheiten |
| US8735074B2 (en) * | 2009-08-28 | 2014-05-27 | Asuragen, Inc. | MiRNA biomarkers of lung disease |
| EP2341145A1 (de) * | 2009-12-30 | 2011-07-06 | febit holding GmbH | miRNA-Fingerabdruck für die Krankheitsdiagnose |
| CN103237901B (zh) * | 2010-03-01 | 2016-08-03 | 卡里斯生命科学瑞士控股有限责任公司 | 用于治疗诊断的生物标志物 |
| EP2744919A4 (de) * | 2011-08-19 | 2015-04-08 | Myriad Genetics Inc | Gensignaturen für lungenkrebsprognose und therapieauswahl |
| EP2751292A4 (de) * | 2011-09-01 | 2015-05-20 | Allegro Diagnostics Corp | Verfahren und zusammensetzungen zum nachweis von krebs auf der basis von mirna-expressionsprofilen |
| WO2014093872A1 (en) * | 2012-12-13 | 2014-06-19 | Baylor Research Institute | Blood transcriptional signatures of active pulmonary tuberculosis and sarcoidosis |
| KR102581812B1 (ko) * | 2014-06-18 | 2023-09-25 | 국립연구개발법인 고쿠리츠간켄큐센터 | 폐암의 검출 키트 또는 디바이스 및 검출 방법 |
-
2020
- 2020-08-26 US US17/003,775 patent/US11198912B2/en active Active
- 2020-08-26 WO PCT/US2020/048019 patent/WO2021041556A1/en unknown
- 2020-08-26 EP EP20857896.3A patent/EP4022094A4/de not_active Withdrawn
- 2020-08-26 EP EP23174278.4A patent/EP4257982A3/de active Pending
- 2020-08-26 JP JP2022513609A patent/JP2023504334A/ja active Pending
-
2021
- 2021-12-14 US US17/551,113 patent/US20220106645A1/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2305811A1 (de) * | 2005-07-27 | 2011-04-06 | Oncotherapy Science, Inc. | Verfahren zur Diagnose von kleinzelligem Lungenkrebs |
| US20110236903A1 (en) * | 2008-12-04 | 2011-09-29 | Mcclelland Michael | Materials and methods for determining diagnosis and prognosis of prostate cancer |
| WO2018213764A1 (en) * | 2017-05-19 | 2018-11-22 | Lunella Biotech, Inc. | Companion diagnostics for mitochondrial inhibitors |
| WO2019008414A1 (en) * | 2017-07-05 | 2019-01-10 | Datar Rajan | GENE EXPRESSION ANALYSIS BASED ON EXOSOMES FOR THE CARE OF CANCER |
Non-Patent Citations (1)
| Title |
|---|
| SOTGIA FEDERICA ET AL: "Mitochondrial markers predict survival and progression in non-small cell lung cancer (NSCLC) patients: Use as companion diagnostics", ONCOTARGET, vol. 8, no. 40, 15 September 2017 (2017-09-15), pages 68095 - 68107, XP055967436, DOI: 10.18632/oncotarget.19677 * |
Also Published As
| Publication number | Publication date |
|---|---|
| US20220106645A1 (en) | 2022-04-07 |
| US20210102261A1 (en) | 2021-04-08 |
| EP4257982A2 (de) | 2023-10-11 |
| JP2023504334A (ja) | 2023-02-03 |
| WO2021041556A1 (en) | 2021-03-04 |
| EP4022094A1 (de) | 2022-07-06 |
| US11198912B2 (en) | 2021-12-14 |
| EP4257982A3 (de) | 2024-03-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4022094A4 (de) | Biomarker zur diagnose von lungenkrebs | |
| EP3606507A4 (de) | Serologische biomarker zur frühdiagnose von lungenkrebs | |
| EP3403093A4 (de) | Plasma-autoantikörper-biomarker zur diagnose von lungenkrebs | |
| EP3630293A4 (de) | Biomarker zur diagnose von lungenkrebs | |
| EP3607089A4 (de) | Plasmabasierte proteinprofilierung für lungenkrebsprognose im frühstadium | |
| EP3947741A4 (de) | Krebsbiomarker für dauerhaften klinischen nutzen | |
| EP3427066A4 (de) | Lipidbiomarker zur krebsdiagnose | |
| EP3836909A4 (de) | Biomarker für die krebstherapie | |
| GB201919219D0 (en) | Cancer biomarkers | |
| EP3740590A4 (de) | Kits und verfahren zur diagnose von lungenkrebs | |
| AU2018290809A1 (en) | Biomarkers for the diagnosis and treatment of fibrotic lung disease | |
| EP3698144A4 (de) | Zusammensetzungen, verfahren und kits zur diagnose von lungenkrebs | |
| EP4082457A4 (de) | Neostomieinstrument | |
| EP3994078A4 (de) | Sonde | |
| EP3926338A4 (de) | Biosensor | |
| EP3585909A4 (de) | Biomarker zur diagnose von störungen | |
| EP4013896A4 (de) | Proteogenomische verfahren zur krebsdiagnose | |
| EP3607066A4 (de) | Verfahren für den nachweis von lungenkrebs | |
| EP3899541C0 (de) | Epitomische biomarker für lungenkrebsproteine | |
| EP3831962A4 (de) | Sonden-/primer-bibliothek zur diagnose von krebs | |
| EP3810807A4 (de) | Verfahren und zusammensetzungen für die analyse von krebsbiomarkern | |
| EP4083627A4 (de) | Prognostischer biomarker von krebs | |
| EP4045905A4 (de) | Methode zum diagnostizieren von nicht-kleinzelligem lungenkrebs im frühstadium | |
| EP3899531A4 (de) | Verfahren für den nachweis von lungenkrebs | |
| EP4038102A4 (de) | Biomarker zur antitigit-antikörperbehandlung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| 17P | Request for examination filed |
Effective date: 20220322 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| A4 | Supplementary search report drawn up and despatched |
Effective date: 20221103 |
|
| DAV | Request for validation of the european patent (deleted) | ||
| DAX | Request for extension of the european patent (deleted) | ||
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: G01N 33/574 20060101ALI20221027BHEP Ipc: C12Q 1/6813 20180101ALI20221027BHEP Ipc: C12Q 1/6876 20180101ALI20221027BHEP Ipc: C12Q 1/6886 20180101AFI20221027BHEP |
|
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 40077301 Country of ref document: HK |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20230603 |